Thiazolidine derivatives and pharmaceutical compositions containing the same
CA 2135474 C · Owner: Ogawa, Kazuo · Inventors: Fukushima, Masakazu; Yano, Shingo; Ogawa, Kazuo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
125-, A thiazolidine derivative represented by the following formula (I):, wherein R1, R2 and R3 may be the same or different and individually represent a hydrogen atom a halogen atom, a lower alkyl group or lower alkoxyl group which may be substituted by one or more halogen atom(s) a hydroxyl, group, a nitro group, an amino group a lower acylamino, group, a mono or di-lower alkylamino group a carboxyl, group, a lower alkoxycarbonyl group a cyano group, a, 2-oxazolyl group, a thiazolidine-2,4-dion-5-ylidene-methyl group or a thiazolidine-2,4-dion-5-ylmethyl group and R1 and R2 may be coupled together to form an alkylene chain -(CH2)p- wherein p stands for 3 4 or 5, or an alkylenedioxy chain …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 7, 1994 and granted November 10, 1998. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 7, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 7, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.